High-Concentration, Low-Volume Subcutaneous Formulation

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Andrew Mitchell, Agilent Advanced Therapeutics

Articles by Andrew Mitchell, Agilent Advanced Therapeutics

Andrew Mitchell, Agilent Advanced Therapeutics, producing biotherapies, from cell bank to commercial launch.

Behind the Scale-Up: From Cell Bank to Commercial Manufacturing

ByAndrew Mitchell, Agilent Advanced Therapeutics

September 2nd 2026

Sponsored

Andrew Mitchell, Agilent Advanced Therapeutics, explains what it actually takes to produce biotherapeutics, from cell bank to commercial launch.

Latest Updated Articles